Terms: = Breast cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Prognosis
1282 results:
1. A novel long non-coding RNA MIR4500HG003 promotes tumor metastasis through miR-483-3p-MMP9 axis in triple-negative breast cancer.
Lin WD; Chang CH; Pan JK; Lin FC; Chen YC; Chen YJ; Wang PS; Hong WQ; Chen SY; Lin CH; Kuo YL; Chung WP; Cheng HC; Hsiao M; Yang CN; Lu PJ
Cell Death Dis; 2024 May; 15(5):310. PubMed ID: 38697967
[TBL] [Abstract] [Full Text] [Related]
2. B7-H3 Expression in breast cancer and Brain Metastasis.
Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
[TBL] [Abstract] [Full Text] [Related]
3. Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.
Lin J; Lin X; Zheng R; Lin K; Khan M; Huang X; Tian Y; Wang B; Xu B; Yuan Y; Huang Z
Chronobiol Int; 2024 Apr; 41(4):587-597. PubMed ID: 38606920
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study.
Peng J; Hong Y; Chen Q; Xu F; Zhang D; Yao J; Zou Q; Yuan L; Li L; Long Q; Liao L; Liu M; Liu X; Wang S; Yi W
Front Endocrinol (Lausanne); 2024; 15():1347762. PubMed ID: 38567311
[TBL] [Abstract] [Full Text] [Related]
5. [Clinicopathological characteristics and immune microenvironment of breast squamous cell carcinoma].
Liang JY; Wang YM; Wen Z; Zhang WH; Gao ZZ; Wang Z; Guo SP
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):337-343. PubMed ID: 38556816
[No Abstract] [Full Text] [Related]
6. Association of hormone receptors and human epidermal growth factor receptor-2/neu expressions with clinicopathologic factors of breast carcinoma: a cross-sectional study in a tertiary care hospital, Kabul, Afghanistan.
Esmat E; Haidary AM; Saadaat R; Rizvi SN; Aleena S; Haidari M; Hofiani SMS; Hussaini N; Hakimi A; Khairy A; Abdul-Ghafar J
BMC Cancer; 2024 Mar; 24(1):388. PubMed ID: 38539179
[TBL] [Abstract] [Full Text] [Related]
7. Cost-effective prognostic evaluation of breast cancer: using a STAR nomogram model based on routine blood tests.
Wei C; Liang Y; Mo D; Lin Q; Liu Z; Li M; Qin Y; Fang M
Front Endocrinol (Lausanne); 2024; 15():1324617. PubMed ID: 38529388
[TBL] [Abstract] [Full Text] [Related]
8. Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer.
Mäenpää N; Tiainen L; Hämäläinen M; Luukkaala T; Tanner M; Lahdenperä O; Vihinen P; Karihtala P; Kellokumpu-Lehtinen PL; Moilanen E; Jukkola A
BMC Cancer; 2024 Mar; 24(1):331. PubMed ID: 38468231
[TBL] [Abstract] [Full Text] [Related]
9. Usefulness of the Palliative Prognostic Index in Predicting prognosis when Considering the Transition from Hospital to Home Care in Patients with Terminal Stage cancer.
Sakaguchi S; Sakaguchi M; Honma S; Yagi T; Osawa G; Hirano A; Yamaguchi H; Hisanaga T; Shiozawa S
J Nippon Med Sch; 2024; 91(1):74-82. PubMed ID: 38462442
[TBL] [Abstract] [Full Text] [Related]
10. Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
Nader-Marta G; Monteforte M; Agostinetto E; Cinquini M; Martins-Branco D; Langouo M; Llombart-Cusac A; Cortés J; Ignatiadis M; Torri V; Apolone G; Cappelletti V; Pruneri G; de Azambuja E; Di Cosimo S
ESMO Open; 2024 Mar; 9(3):102390. PubMed ID: 38460249
[TBL] [Abstract] [Full Text] [Related]
11. Pure Mucinous Carcinoma of the breast: Radiologic-Pathologic Correlation.
Kuzmiak CM; Calhoun BC
J Breast Imaging; 2023 Mar; 5(2):180-187. PubMed ID: 38416927
[TBL] [Abstract] [Full Text] [Related]
12. Potential of the postoperative lymphocyte-to-monocyte and monocyte-to-red blood cell ratio in predicting locoregional and distant metastases after breast cancer resection - Retrospective study.
Grupińska J; Budzyń M; Janowski J; Brzeziński J; Gryszczyńska B; Leporowska E; Formanowicz D; Kycler W
Adv Med Sci; 2024 Mar; 69(1):103-112. PubMed ID: 38394965
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation and validation of neutrophil to albumin ratio as a promising prognostic marker for all-cause mortality in patients with cancer: a multicenter cohort study.
Xie H; Jia P; Wei L; Ruan G; Zhang H; Ge Y; Lin S; Song M; Wang Z; Liu C; Shi J; Liu X; Yang M; Zheng X; Chen Y; Zhang X; Shi H
Nutrition; 2024 May; 121():112365. PubMed ID: 38377700
[TBL] [Abstract] [Full Text] [Related]
14. Raman spectroscopy combined with multivariate statistical algorithms for the simultaneous screening of cervical and breast cancers.
Cao Y; Xiong J; Du Y; Tang Y; Yin L
Lasers Med Sci; 2024 Feb; 39(1):68. PubMed ID: 38374512
[TBL] [Abstract] [Full Text] [Related]
15. Encapsulated Rose Bengal Enhances the Photodynamic Treatment of Triple-Negative breast cancer Cells.
Uddin MMN; Bekmukhametova A; Antony A; Barman SK; Houang J; Wu MJ; Hook JM; George L; Wuhrer R; Mawad D; Ta D; Ruprai H; Lauto A
Molecules; 2024 Jan; 29(2):. PubMed ID: 38276623
[TBL] [Abstract] [Full Text] [Related]
16. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
[TBL] [Abstract] [Full Text] [Related]
17. Nanoemulsion potentiates the anti-cancer activity of Myricetin by effective inhibition of PI3K/AKT/mTOR pathway in triple-negative breast cancer cells.
Sharma P; Chaturvedi S; Khan MA; Rai Y; Bhatt AN; Najmi AK; Akhtar M; Mishra AK
Med Oncol; 2024 Jan; 41(2):56. PubMed ID: 38218749
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value of insulin resistance in patients with female reproductive system malignancies: A multicenter cohort study.
Liu XY; Zhang Q; Zhang X; Ge YZ; Ruan GT; Xie HL; Liu T; Song MM; Deng L; Shi HP
Immun Inflamm Dis; 2023 Dec; 11(12):e1107. PubMed ID: 38156375
[TBL] [Abstract] [Full Text] [Related]
19. The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience.
Hong YW; Kuo IM; Kuo WL; Yu CC; Shen SC; Tsai HP; Chu CH; Ho HY; Lo YF; Chen SC; Lin YC; Chien CY; Chou HH
Breast Cancer; 2024 Mar; 31(2):252-262. PubMed ID: 38150135
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer: a Dutch population-based study.
de Wild SR; Koppert LB; de Munck L; Vrancken Peeters MTFD; Siesling S; Smidt ML; Simons JM
Breast Cancer Res Treat; 2024 Apr; 204(2):277-288. PubMed ID: 38133707
[TBL] [Abstract] [Full Text] [Related]
[Next]
